Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - sofosbuvir 400mg;  ;  ;   - film coated tablet - 400 mg - active: sofosbuvir 400mg       excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose opadry yellow 85f92259 purified water - sovaldi is indicated in combination with other agents for the treatment of chronic hepatitis c (chc) in adults and in pediatric patients 12 years of age and older or weighing at least 35 kg with genotype 2 or 3, without cirrhosis or with compensated cirrhosis.

Union européenne - anglais - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c, chronic - antivirals for systemic use - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (see sections 4.2, 4.4 and 5.1).

Union européenne - anglais - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitis c, chronic - antivirals for systemic use - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4.2, 4.4 and 5.1).

Union européenne - anglais - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir - hepatitis c, chronic - antivirals for systemic use - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1).for hepatitis c virus (hcv) genotype specific activity, see sections 4.4 and 5.1.sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4.2, 4.4 and 5.1).for hepatitis c virus (hcv) genotype specific activity, see sections 4.4 and 5.1.

Israël - anglais - Ministry of Health

gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.

Israël - anglais - Ministry of Health

gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.

Canada - anglais - Health Canada

bayer inc - gadofosveset trisodium - solution - 244mg - gadofosveset trisodium 244mg - other diagnostic agents

Canada - anglais - Health Canada

lantheus mi canada inc - gadofosveset trisodium - solution - 244mg - gadofosveset trisodium 244mg - other diagnostic agents

Canada - anglais - Health Canada

gilead sciences canada inc - sofosbuvir; velpatasvir; voxilaprevir - tablet - 400mg; 100mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg; voxilaprevir 100mg - hcv polymerase inhibitors

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ge healthcare bv-srl - tetrofosmin 0,23 mg - kit for radiopharmaceutical preparation - 230 µg - tetrofosmin 0.23 mg - technetium (99mtc) tetrofosmin